Literature DB >> 25873795

Echocardiographic versus histologic findings in Marfan syndrome.

Xiaoyan Gu, Yihua He, Zhian Li, Jiancheng Han, Jian Chen, J V Ian Nixon.   

Abstract

This retrospective study attempted to establish the prevalence of multiple-valve involvement in Marfan syndrome and to compare echocardiographic with histopathologic findings in Marfan patients undergoing valvular or aortic surgery. We reviewed echocardiograms of 73 Marfan patients who underwent cardiovascular surgery from January 2004 through October 2009. Tissue histology was available for comparison in 29 patients. Among the 73 patients, 66 underwent aortic valve replacement or the Bentall procedure. Histologic findings were available in 29 patients, all of whom had myxomatous degeneration. Of 63 patients with moderate or severe aortic regurgitation as determined by echocardiography, 4 had thickened aortic valves. The echocardiographic findings in 18 patients with mitral involvement included mitral prolapse in 15. Of 11 patients with moderate or severe mitral regurgitation as determined by echocardiography, 4 underwent mitral valve repair and 7 mitral valve replacement. Histologic findings among mitral valve replacement patients showed thickened valve tissue and myxomatous degeneration. Tricuspid involvement was seen echocardiographically in 8 patients, all of whom had tricuspid prolapse. Two patients had severe tricuspid regurgitation, and both underwent repair. Both mitral and tricuspid involvement were seen echocardiographically in 7 patients. Among the 73 patients undergoing cardiac surgery for Marfan syndrome, 66 had moderate or severe aortic regurgitation, although their valves manifested few histologic changes. Eighteen patients had mitral involvement (moderate or severe mitral regurgitation, prolapse, or both), and 8 had tricuspid involvement. Mitral valves were most frequently found to have histologic changes, but the tricuspid valve was invariably involved.

Entities:  

Keywords:  Aortic valve regurgitation; Marfan syndrome/complications/pathology/ultrasonography; cardiovascular abnormalities/epidemiology; echocardiography; mitral valve prolapse; pulmonary valve regurgitation; tricuspid valve regurgitation

Mesh:

Year:  2015        PMID: 25873795      PMCID: PMC4378039          DOI: 10.14503/THIJ-13-3848

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  24 in total

1.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

2.  Myxomatous mitral valve disease and related entities: The role of matrix in valvular heart disease.

Authors:  W M Lester
Journal:  Cardiovasc Pathol       Date:  1995 Oct-Dec       Impact factor: 2.185

3.  Mechanisms of aortic valve incompetence: finite-element modeling of Marfan syndrome.

Authors:  K J Grande-Allen; R P Cochran; P G Reinhall; K S Kunzelman
Journal:  J Thorac Cardiovasc Surg       Date:  2001-11       Impact factor: 5.209

4.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease).

Authors:  Patrizio Lancellotti; Christophe Tribouilloy; Andreas Hagendorff; Luis Moura; Bogdan A Popescu; Eustachio Agricola; Jean-Luc Monin; Luc A Pierard; Luigi Badano; Jose L Zamorano
Journal:  Eur J Echocardiogr       Date:  2010-04

5.  Cardiovascular manifestations in Marfan syndrome.

Authors:  S Figueiredo; E Martins; M R Lima; S Alvares
Journal:  Rev Port Cardiol       Date:  2001-12       Impact factor: 1.374

6.  [Prevalence of cardiovascular manifestations in Marfan syndrome].

Authors:  Maria Cristina Porciani; Monica Attanasio; Valentina Lepri; Ilaria Lapini; Gabriele Demarchi; Luigi Padeletti; Guglielmina Pepe; Rosanna Abbate; Gian Franco Gensini
Journal:  Ital Heart J Suppl       Date:  2004-08

7.  Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome.

Authors:  K J Fleischer; H C Nousari; G J Anhalt; C D Stone; J C Laschinger
Journal:  Ann Thorac Surg       Date:  1997-04       Impact factor: 4.330

8.  Mitral valve prolapse in Marfan syndrome: an old topic revisited.

Authors:  Cynthia C Taub; Joan M Stoler; Teresa Perez-Sanz; John Chu; Eric M Isselbacher; Michael H Picard; Arthur E Weyman
Journal:  Echocardiography       Date:  2008-11-24       Impact factor: 1.724

9.  Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1.

Authors:  R E Magenis; C L Maslen; L Smith; L Allen; L Y Sakai
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

Review 10.  Mitral valve billowing and prolapse--an overview.

Authors:  J B Barlow
Journal:  Aust N Z J Med       Date:  1992-10
View more
  5 in total

Review 1.  Cardiovascular Management of Adults with Marfan Syndrome.

Authors:  Yukiko Isekame; Sabiha Gati; Jose Antonio Aragon-Martin; Rachel Bastiaenen; Sreenivasa Rao Kondapally Seshasai; Anne Child
Journal:  Eur Cardiol       Date:  2016-12

2.  Clinical features and histopathological analysis of corneal myxoma.

Authors:  Bader S Al-Qahtani; Hind M Alkatan; Rajiv Khandekar; Ahmed Al-Salem; Samar A Al-Swailem
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

3.  The role of elastin on the mechanical properties of the anterior leaflet in porcine tricuspid valves.

Authors:  Samuel D Salinas; Yasmeen M Farra; Keyvan Amini Khoiy; James Houston; Chung-Hao Lee; Chiara Bellini; Rouzbeh Amini
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.240

4.  Genotype-Phenotype Correlation in Children: The Impact of FBN1 Variants on Pediatric Marfan Care.

Authors:  Veronika C Stark; Flemming Hensen; Kerstin Kutsche; Fanny Kortüm; Jakob Olfe; Peter Wiegand; Yskert von Kodolitsch; Rainer Kozlik-Feldmann; Götz C Müller; Thomas S Mir
Journal:  Genes (Basel)       Date:  2020-07-15       Impact factor: 4.096

5.  Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition.

Authors:  Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.